XTL-001, a combination of 2 monoclonal antibodies, shows activity in chronic hepatitis B

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1263, 2000-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The monoclonal antibody XTL 002 [HCV-AB68] has potential in the treatment of chronic hepatitis C virus (HCV) infection

Inpharma, Vol. 1, Iss. 1578, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Peginterferon alfa-2b and ribavirin combination therapy for chronic hepatitis C

By Yeh Frank Gordon Fredric D

Future Virology, Vol. 2, Iss. 6, 2007-11 ,pp. : 553-563

Future Medicine

Access to resources Recommend Favorite

Emtricitabine shows antiviral activity in patients with chronic hepatitis B virus (HBV) infection

Inpharma, Vol. 1, Iss. 1263, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Everolimus [RAD 001], in combination with octreotide long-acting repeatable (LAR), shows promising antitumour activity

Inpharma, Vol. 1, Iss. 1657, 2008-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Peginterferon- -2a superior to lamivudine for chronic hepatitis B

Inpharma, Vol. 1, Iss. 1456, 2004-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite